Broadening T1D R&D funding sources

Last year JDRF took a number of significant actions to broaden the resources available in the T1D research and development space – three of them are highlighted here. Each of these will help speed progress towards our research goals across our portfolio of research objectives to develop and deliver novel T1D therapies to patients. In […]

Inhaled insulin shows value in artificial pancreas study

Last September, results from a JDRF-funded study were announced by Sansum Diabetes Research Institute and JDRF. This study addresses one of the key limitations of early artificial pancreas systems – the challenge of mealtime dosing of insulin. This is because insulin delivered through the skin by a pump or injections works much slower than insulin […]

Accelerating development progress of artificial pancreas systems

Last September, Medtronic announced FDA approval of its MiniMed 530G with Enlite system (sold outside the United States as the Veo since 2009). JDRF applauded the U.S. Food and Drug Administration (FDA) for its commitment to ensuring patients in the United States can access insulin pumps that can temporarily stop insulin delivery once sensor glucose […]

T1D in the Fast Lane

JDRF and Ford Customer Service Division (FCSD) joined forces to help raise awareness and funds for type 1 diabetes (T1D) research through the “Our Everyday Heroes” Race Car Design Contest for JDRF. The winning design was painted onto the Motorcraft/Quick Lane Ford Shelby Mustang Funny Car driven by Bob Tasca III. The contest has raised […]